The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.

The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.

From a young age, Emily Naismith watched her peers die from cystic fibrosis. The drug Trikafta gave her a future but she says forming a new identity has been complex.

Access to Trikafta is now at risk for several hundred people with cystic fibrosis, thanks to what some might consider to be good intentions. Skip to Main Content. research. FDA. patients.

Patients, doctors worry "miracle" drug may no longer be available in Colorado 04:24. Some Coloradans are sounding an alarm after learning a state board is considering capping the price of a life ...

Trio of scientists who developed the combination drug Trikafta are among the winners of five major awards in life sciences, physics and mathematics. Skip to main content Thank you for visiting ...

BOSTON, December 20, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor ...

In 2019, the FDA approved the drug Trikafta, which was developed by researchers at Vertex Pharmaceuticals. What’s remarkable about the drug is that it’s effective for over 90% of patients, ...

RALEIGH. When he was about 14, Pete Proimos learned a soul-crushing statistic about the cystic fibrosis he’d endured since birth: Patients back then didn’t live much past high school.

Colorado’s new prescription drug review board decided that a medication costing more than $200,000 a year doesn’t qualify as “unaffordable,” based on the drug’s benefits to patients and ...